폰아르(FONR) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

🏛️

거래 정지 중인 종목 2026-06-29 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.

FONR

Fonar Corp

6월 2일 4:00 PM ET (한국 6/3 05:00)

$19.09

+0.00 +0.00%

폰아르(FONR) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$120M

스몰캡

P/E

19.1

적정 수준

배당수익률

없음

52주 위치

99%

저점 +40% · 고점 -0%

애널리스트

C+

Fundamental health

vs. Diagnostics & Research

수익성

Top 21%

성장

Top 63%

밸류에이션

Top 92%

재무 안정

Top 22%

Index ⓘ	-	P/E ⓘ	19.15	EPS (ttm) ⓘ	1	Insider Own ⓘ	21.99%	Shs Outstand ⓘ	6.2M	Perf Week ⓘ	-
Market Cap ⓘ	0.12B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	67.01%	Shs Float ⓘ	4.9M	Perf Month ⓘ	1.22%
Enterprise Value ⓘ	0.09B	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	46.91%	Short Float ⓘ	0.97%	Perf Quarter ⓘ	3.58%
Income ⓘ	0.01B	P/S ⓘ	1.14	EPS this Y ⓘ	-	Inst Trans ⓘ	-	Short Ratio ⓘ	0.59	Perf Half Y ⓘ	33.96%
Sales ⓘ	0.11B	P/B ⓘ	0.67	EPS next 5Y ⓘ	-	ROA ⓘ	3.08%	Short Interest ⓘ	0.05M	Perf YTD ⓘ	2.86%
Book/sh ⓘ	28.46	P/C ⓘ	2.23	EPS past 3/5Y ⓘ	-11.05% 0.9%	ROE ⓘ	3.82%	52W High ⓘ	-0.34% ($19.16)	Perf Year ⓘ	31.66%
Cash/sh ⓘ	8.56	P/FCF ⓘ	25.67	Sales past 3/5Y ⓘ	2.26% 4.02%	ROIC ⓘ	3.14%	52W Low ⓘ	40.16% ($13.62)	Perf 3Y ⓘ	13.43%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	6.42	EPS Y/Y TTM ⓘ	-19.05%	Gross Margin ⓘ	40.26%	Volatility(W/M) ⓘ	0.43% 0.26%	Perf 5Y ⓘ	5.82%
Dividend TTM ⓘ	-	EV/Sales ⓘ	0.86	Sales Y/Y TTM ⓘ	2.25%	Oper. Margin ⓘ	9.05%	ATR (14) ⓘ	0.05	Perf 10Y ⓘ	16.12%
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	9	EPS Q/Q ⓘ	-34.52%	Profit Margin ⓘ	6.05%	RSI (14) ⓘ	75.02	Recom ⓘ	-
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	9.18	Sales Q/Q ⓘ	-2.55%	SMA20 ⓘ	0.86% ($18.93)	Beta ⓘ	0.95	Target Price ⓘ	-
Payout ⓘ	-	Debt/Eq ⓘ	0.22	Earnings ⓘ	-	SMA50 ⓘ	1.57% ($18.79)	Rel Volume ⓘ	0	Prev Close ⓘ	$19.09
Employees ⓘ	535	LT Debt/Eq ⓘ	0.19	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	12.29% ($17)	Avg Volume(3M) ⓘ	0.08M	Price ⓘ	$19.09
IPO ⓘ	1981/10/23	Option/Short ⓘ	No/No			Trades ⓘ	0	Volume ⓘ	-	Change ⓘ	-

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 Fonar Corp (FONR) Investment Analysis

What kind of company is Fonar Corp?

폰아르(FONR) 가치주

Healthcare · Diagnostics & Research

Small-Cap — Low Volume, High Volatility

A specialized medical device company that developed the world's first commercial MRI, holding a unique Stand-Up MRI technology. The company generates stable revenue through the manufacturing of innovative diagnostic equipment that allows patients to be scanned while seated or standing, as well as through the operation of large-scale imaging diagnostic center management services.

Learn more about Fonar Corp →

Market Cap

$0.1B

Approx. KRW 0.2 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank4452

Employees535people

IPO1981/10/23

Current Price$19.09 ≈ 26,153원

NASD · USA

Key Events

예정된 이벤트가 없습니다

FONR의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

실적 발표는 보통 분기마다 있습니다
배당주는 연 1~4회 배당락일이 있습니다

전체 경제/실적 캘린더 보기 →

Is it profitable?

Solid company — profitability & finances both healthy

Strong earnings and excellent financial health

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

9.1%

✓ 양호

My positionMid-range

Low range Average High range

Diagnostics & Research Median -6.9% · Top 33%

💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수

Net Margin

Share of revenue left after taxes and interest are paid

6.0%

✓ 양호

My positionMid-range

Low range Average High range

Diagnostics & Research Median -3.8% · Top 32%

💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

40.3%

✓ 평균

My positionMid-range

Low range Average High range

Diagnostics & Research Median 52.1% · Bottom 38%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

3.8%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -98.0% · Top tier

💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)

ROA

Annual earnings relative to total company assets

3.1%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -59.3% · Top tier

💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수

ROIC

Return generated per dollar invested in the business

3.1%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -77.3% · Top tier

💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.22

✓ Healthy debt

My positionMid-range

Low range Average High range

Diagnostics & Research Median 0.38

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

9.18

✓ 우수

My positionTop 5%

Low range Average High range

Diagnostics & Research Median 2.23

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

9.00

✓ 우수

My positionTop 5%

Low range Average High range

Diagnostics & Research Median 2.15

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Outlook data is insufficient

Analyst estimates and price targets have not been collected.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth

Mid-range within the industry

Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

-11.1%

평균

My positionMid-range

Low range Average High range

가치주 초소형주 Median 2.4% · Bottom 34%

Past 5-Year EPS

Actual average annual EPS growth over the past 5 years

+0.9%

평균

My positionMid-range

Low range Average High range

가치주 초소형주 Median 9.4% · Bottom 39%

Past 5-Year Revenue

How much revenue grew over the past 5 years

+4.0%

평균

My positionMid-range

Low range Average High range

가치주 초소형주 Median 7.3% · Bottom 41%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

-2.5%

평균

My positionMid-range

Low range Average High range

가치주 초소형주 Median 5.3% · Bottom 34%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -63%p below the market

FONR +5.8% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-62.5%p

Significantly behind the market

vs Health Care (XLV)

-18.7%p

behind the sector average

1-year basis

vs S&P 500

+15.6%p

ahead of the market

vs Health Care (XLV)

+11.9%p

ahead of the sector average

Rank among peers

5-year return Top among peers Based on 10 peers

1-year return Upper-Mid (35%) Based on 14 peers

Current position within 52-week range

Low (-40.2%p) High (-0.3%p)

Current price is 40.2% above the 52-week low and 0.3% below the 52-week high

Recent risk (last 100 trading days)

Max drawdown

-2.0%

Annualized volatility

3.5%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 107-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟡

Current diagnosis · 2026-06-12

Squeeze — volatility contraction, breakout imminent

Band width narrowed to 2.0%. Big move may be near. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-06-12

Neutral zone — weak trend

MACD 0.068 · Signal 0.072 · Hist -0.004. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

⚠️

Current diagnosis · 2026-06-12

Overbought zone — short-term pullback possible

RSI 75.0 (above 70). Buying pressure is excessive, and profit-taking may emerge. Stoch %K is also 74.5.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Earnings·Vs. Assets·Vs. Sales·Vs. Cash Flow

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Cheap

🧾 Vs. Sales Cheap

💧 Vs. Cash Flow Cheap

💵 Vs. Earnings

PER Price-to-Earnings Ratio

How expensive the price is vs. earnings — lower is cheaper

19.15x

✓ Very cheap

My positionTop 5%

Low range Average High range

Diagnostics & Research median 35.22x · Top 1% — relatively cheap within the industry

💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

0.67x

✓ Very cheap

My positionTop 5%

Low range Average High range

Diagnostics & Research median 3.37x · Top 1% — relatively cheap within the industry

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

1.14x

✓ Very cheap

My positionTop 25%

Low range Average High range

Diagnostics & Research median 4.06x · Top 11% — relatively cheap within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

💧 Vs. Cash Flow

EV/EBITDA Enterprise Value Multiple

Total enterprise value ÷ operating cash earnings — a benchmark for M&A

6.42x

✓ Very cheap

My positionTop 5%

Low range Average High range

Diagnostics & Research median 22.23x · Top 1% — relatively cheap within the industry

💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)

💧 Vs. Cash Flow

P/FCF Price-to-Free-Cash-Flow Ratio

Price vs. actual cash generation — lower means more efficient

25.67x

✓ Cheap

My positionMid-range

Low range Average High range

Diagnostics & Research median 29.34x · Around the industry average

💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Diagnostics & Research

Who owns it?

Ownership flow is positive

Insider net buying +67.0% · Short interest light 1.0% · Short interest up +0.8pp over last 90d

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

+67.0%

Insiders large net buying

🏦 Institutions (funds & investors)

No trading data for Institutions

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 46.9%

Moderate institutional participation

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 22.0%

Founder/management large holders (strong skin-in-the-game)

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 31.1%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

1.0%

Low — limited short-side pressure

Healthcare 초소형주 Median 3.9%

Past 90 days 📈 +0.8%p increase

Short interest days to cover

0.6 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 6.2M주

Float (tradable shares) 4.9M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding FONR

ETFs with the highest weightings · 10 total shown

IWC

iShares Micro-Cap ETF

0.02%

$1.4B

AVUV

Avantis U.S. Small Cap Value ETF

0.00%

$30.0B

DCOR

Dimensional US Core Equity 1 ETF

0.00%

$3.3B

DFAC

Dimensional U.S. Core Equity 2 ETF

0.00%

$47.5B

DFAS

Dimensional U.S. Small Cap ETF

0.00%

$15.2B

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
FONR This Stock	$119.9M	19.1 ▲	0.7 ▲	3.82% ▲	-	+0.0%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 폰아르(FONR)?

폰아르(FONR) belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is the market cap of FONR?

The market cap of FONR is approximately $120M, ranking 4,452 within its sector.

What is the P/E ratio of FONR?

FONR has a P/E ratio of approximately 19.1x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for FONR?

FONR has recorded a 52-week high of $19.16 and a low of $13.62.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.